NUP93 and breast carcinoma: Our data, confirmed by in vivo experiments and by immunofluorescence of human triple-negative, claudin-low breast cancer samples of different stages provide mechanistic evidence of the role of Nup93 in breast cancer progression and highlight potential novel targets for the development of anti-metastatic therapies.